Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.
The Scientist
Most Recent
Sheng Wang leaves the Boston University School of Medicine and agrees to retract two published studies.
Repurposing patient’s own T-cells to recognize antigens on cancer cells caused dramatic improvement in three patients with chronic lymphocytic leukemia.
Improved immunization efforts are required to prevent infections during the first 6 months of life, when newborn and infants are highly susceptible to disease.
Researchers identify new mutations in schizophrenia patients without a family history of the disease.
Researchers identify an antibody profile that may mark patients who suffer persistent symptoms of the tick-borne disease.
A single fungal species can form two different kinds of biofilms—a pathogenic one and a sexual one.
The addictive component of cigarettes saves dopamine neurons from a Parkinson's-like decline, providing a new avenue for potential treatment.
When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. Undeterred, he helped convert a former kitchen in the Korogwe District Hospital into a small mal
While gut microbiota appear to have both positive and negative impacts on our health, in the guts of healthy, lean individuals, the good outweighs the bad. Gut bacteria, most of which reside in the large intestine, process many otherwise indigest
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
